GlaxoSmithKline (
$GSK) will turn to outsourcing to replace APIs made at an Indian plant on its way to closure. Rather than sink more capital into improving the Thane, India, plant, the company will contract for those ingredients, which are "available at competitive prices from third-party manufacturers in India," a spokeswoman said. Some 330 employees are taking "voluntary retirement."
About US
Contact us
